{
    "nctId": "NCT01431053",
    "briefTitle": "Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer",
    "officialTitle": "Phase 2 Study of Aspirin Plus Exemestane Comparing With Exemestane Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 160,
    "primaryOutcomeMeasure": "Quality of Life",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer after surgery postmenopausal\n\nExclusion Criteria:\n\n* contraindication of aspirin",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}